Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Inotek describes novel PARP inhibitors

July 21, 2010

Aegera reports survival data from phase I AEG-35156 combination trial

July 21, 2010

German scientists disclose new HIF-mediated transcription inhibitors

July 21, 2010

CytRx advances its bafetinib program in oncology

July 21, 2010

Archer Biosciences begins dosing in third cohort of TPI-287 trial in metastatic melanoma

July 21, 2010

Hexyl/methyl aminolevulinate photodynamic therapy does not damage cervical tissue

July 21, 2010

Ziopharm begins phase III palifosfamide trial in metastatic soft tissue sarcoma

July 21, 2010

Geron begins phase II imetelstat trial in advanced non-small cell lung cancer

July 20, 2010

Jevtana launched in U.S. for metastatic hormone-refractory prostate cancer

July 20, 2010

Health Canada clears phase III ReoT3D trial in head and neck cancer

July 20, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...